Clene (CLNN) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $48.00 price target on the stock.
Clene (CLNN) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $23.00 price target on the stock.
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights [Yahoo! Finance]
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway [Yahoo! Finance]